HomeCRNX • NASDAQ
add
Crinetics Pharmaceuticals Inc
Previous close
$48.50
Day range
$40.04 - $47.56
Year range
$35.24 - $62.53
Market cap
3.76B USD
Avg Volume
652.44K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 25.89M | 67.22% |
Net income | -76.83M | -33.71% |
Net profit margin | — | — |
Earnings per share | -0.96 | 4.95% |
EBITDA | -87.03M | -48.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 862.67M | 55.53% |
Total assets | 937.37M | 46.11% |
Total liabilities | 104.39M | 11.31% |
Total equity | 832.98M | — |
Shares outstanding | 92.74M | — |
Price to book | 4.71 | — |
Return on assets | -23.44% | — |
Return on capital | -24.81% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -76.83M | -33.71% |
Cash from operations | -62.82M | -51.97% |
Cash from investing | 20.60M | 110.66% |
Cash from financing | 57.33M | -83.03% |
Net change in cash | 15.11M | -85.37% |
Free cash flow | -40.36M | -62.16% |
About
Founded
Nov 18, 2008
Website
Employees
290
